Sweden· SE-20150922000016
Somatuline Autogel 60 mg Injektionsvätska, lösning i förfylld spruta
A medicinal product containing lanreotide, registered in Sweden by Medartuum AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Lanreotide
- Manufacturer
- Medartuum AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20150922000016
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lanreotide in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainSOMATULINA AUTOGEL 60 mg SOLUCION INYECTABLE EN JERINGA PRECARGADAIpsen Pharma S.A.U.
- NetherlandsLanreotide SUN 120 mg oplossing voor injectie in een voorgevulde spuitSun Pharmaceutical Industries Europe B.V.
- United KingdomLanreotide 120mg/0.5ml solution for injection pre-filled syringesSun Pharma UK Ltd
- PolandLanreotide RanbaxyRanbaxy (Poland) Sp. z o.o.
- IrelandLanreotide SUN 120 mg solution for injection in a pre-filled syringeSun Pharmaceutical Industries Europe B.V.
- NorwayIpstyl AutogelInstitut Produits Synthèse (IPSEN) AB
- FranceMYRELEZ L.P. 120 mg, solution injectable à libération prolongée en seringue préremplieAMDIPHARM
- GermanyLanreotid SunSun Pharmaceuticals Germany Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Lanreotid Sun Pharma, Lanreotid Viatris
- Belgium · Lanreotide Sun, Lanreotide Viatris
- Cyprus · Somatuline Autogel
- Czechia · Lanreotid Sun, Lanreotid Zentiva
- Germany · Lanreotid Sun, Lanreotid Viatris
- Denmark · Ipstyl Autogel, Lanreotid Amdipharm Limited
- Estonia · Myrelez, Somatuline Autogel
- Spain · Lanreotida Sun, Lanreotida Zentiva
- Finland · Lanreotid Sun, Lanreotid Zentiva
- France · Lanreotide L.P. Biogaran, Lanréotide Viatris Lp
- United Kingdom (Northern Ireland) · Lanreotide Mylan, Lanreotide Zentiva
- Greece · Lanrod, Myrelez
- Hungary · Lanreotid Sun, Somatuline Autogel
- Ireland · Lanreotide Sun, Lanreotide Viatris
- Italy · Ipstyl, Lanrenet
- Lithuania · Myrelez, Somatuline Autogel
- Luxembourg · Somatuline Autogel Injectable, Somatuline Autogel Injectable120
- Latvia · Myrelez, Somatuline Autogel
- Netherlands · Lanreotide Sun, Mytolac
- Norway · Ipstyl Autogel, Lanreotid Sun
- Poland · Lanreotide Zentiva, Myrelez
- Portugal · Myrelez, Somatulina Autogel
- Romania · Lanreotidă Terapia, Lanreotidă Zentiva
- Slovenia · Somatuline Autogel
- Slovakia · Lanreotid Sun, Lanreotid Zentiva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9727af0-a361-40ad-9c25-36f6c1e75dc9 GET /v1/drugs/d9727af0-a361-40ad-9c25-36f6c1e75dc9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20150922000016",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150922000016",
"product_doc_link": "https://docetp.mpa.se/LMF/Somatuline%20Autogel%2060%20mg%20120%20mg%20solution%20for%20injection%20pre-filled%20syringe%20CZ%20PL_09001bee82738384.pdf"
}See everything about lanreotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.